The purpose of the study is to develop a personalized, user-friendly computerized treatment for anxiety disorders linked to primary care. The computerized treatment is a type of Cognitive Bias Modification, which targets attention and interpretation biases known to maintain anxiety disorders.
The primary goals of our 3-year, 2-phase project are to develop AIM for primary care linkage and assess its feasibility and acceptability. This protocol description only pertains to Phase 2 (Randomized Controlled Trial). 42 primary care patients with primary Generalized Anxiety Disorder, Social Anxiety Disorder, and/or Panic Disorder (with or without Agoraphobia) will be randomly assigned to the AIM treatment or to a symptom tracking control group. Full assessments will occur pre- and post-treatment and 3-months follow-up. A mid-treatment assessment will include measures of cognitive biases and the primary outcome. Weekly measures of anxiety and depression will be collected, as will feedback from patients and PCPs about the research and delivery procedures.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
Computerized treatment targeting mental habits and primary care linkage.
Weekly self-assessment with validated questionnaires and primary care linkage
Family Care Center at Memorial Hospital of Rhode Island
Pawtucket, Rhode Island, United States
Hamilton Anxiety Rating Scale
Number of participants who achieved a 20% reduction in their interview-administered Hamilton Anxiety Rating Scale Total Score.
Time frame: 6-8 weeks after first treatment session
7-item Generalized Anxiety Disorder Scale
Time frame: 6-8 weeks after first treatment session
Patient Health Questionnaire-9
Time frame: 6-8 weeks after first treatment session
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.